Ann: Investor Presentation, page-12

IVX only have rights to Asia Pacific not including China but are funding trials that I presume would be accepted everywhere e.g. the big markets of the USA & Europe. Do IVX get anything back for this external benefit they will be providing?

Do they / will they have any 100% owned IP associted with these therapies that they can earn from globaly?

Even in the restricted market, it looks like a great story, especially at these prices. It is going to be interesting to see how it gos as trials get underway and especialy when they are successful, which seems a likely outcome form the interviews description of the work to date in animal models etc.

It woul be nce to see my 3 million oppies at 33 cents before exercise date - we can only dream!